Clinical studies show semaglutide users experience average triglyceride reductions of 1025% and modest LDL improvements in some cohorts
Hector Perez, MD, a board certified bariatric surgeon at Renew Bariatrics and an advisor at BestSurgeons.com, who was not involved in the study, said that while the risk for ION is worth monitoring, the study is very small
Semaglutide Tablets: Types, Uses, Guidelines And Side Effects 03 Jan 2024 10 min 3173 Views Hello readers
Zepbound, another Tirzepatide-based drug for weight loss, is under consideration and hasnt been approved yet
[15] As use continues to expand across both diabetes and obesity indications, emergency physicians are increasingly encountering patients on these therapies and their associated complications in the ED
Note: Anti-Obesity GLP-1s Wegovy and Zepbound